QDEL Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
630.9M
+1.8%
619.8M
-14.3%
723.6M
+3.4%
699.9M
+14.0%
613.9M
Cost of Revenue
358.0M
+0.6%
356.0M
-11.7%
403.2M
+10.7%
364.3M
+7.5%
339.0M
Gross Profit
272.9M
+3.4%
263.8M
-17.7%
320.4M
-4.5%
335.6M
+22.1%
274.9M
Operating Expenses
294.7M
-0.3%
295.6M
-23.6%
386.7M
-62.8%
1.0B
+128.4%
455.6M
R&D
48.7M
+8.5%
44.9M
-2.0%
45.8M
+10.4%
41.5M
-9.2%
45.7M
SG&A
189.7M
-4.8%
199.3M
+2.5%
194.4M
+4.0%
186.9M
+5.0%
178.0M
Operating Income
-21800000
+31.4%
-31800000
+52.0%
-66300000
+90.6%
-704800000
-290.0%
-180700000
EBITDA
101.4M
+18.6%
85.5M
+13.7%
75.2M
-52.2%
157.3M
+45.0%
108.5M
Net Income
-92900000
-1.2%
-91800000
+29.8%
-130700000
+82.2%
-733000000
-187.0%
-255400000
EPS (Basic)
$-1.36
-0.7%
$-1.35
+29.7%
$-1.92
+82.2%
$-10.78
-185.9%
$-3.77
EPS (Diluted)
$-1.36
-0.7%
$-1.35
+29.7%
$-1.92
+82.2%
$-10.78
-185.9%
$-3.77
Shares (Diluted)
68.3M
+0.1%
68.2M
+0.3%
68.0M
+0.0%
68.0M
+0.4%
67.7M
QuidelOrtho (QDEL) โ€” Financials